Total Funding
4
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
4106107
Transbiomed is a Spain-based biotechnology company developing a urine test for the early detection and diagnosis of prostate cancer.
Andreas Doll: Founding partner, R&D&i
Miguel Abal: Co-Founder
About the Company
Transbiomed is a Barcelona, Spain-based biotechnolgy company. The company, has developed a urine test that allows early diagnosis of prostate cancer and intends to use the funding to begin clinical validation of its innovations in different Spanish hospitals. Transbiomed aims to propose the device as an alternative to biopsy to determine the
existence of this type of cancer. The target is to start commercializing the device by 2013.
